Muxian Zhang

1.1k citations
6 papers · 736 indexed · 1 hit paper · h-index 5

Muxian Zhang

6 papers receiving 730 citations

Hit Papers

TREM2 Is a Receptor for β-Amyloid that Mediates Microglia...5192018202620202023100200300400500

Peers

Muxian Zhang
Comparison fields: 5 of 77
  • Neurology 423
  • Biological Psychiatry 94
  • Physiology 325
  • Immunology 209
  • Physiology 24
Replace Alexander A. Loboda with:
Alexander A. Loboda United States
Shoutang Wang China
Jessica Dalsing-Hernandez United States
Ruying Fu China
Edsel M. Abud United States
Ron Strohmeyer United States
Woochan Lee South Korea
Maria Cimpean United States
Gabriele Tosadori Italy
Muxian Zhang relative to Alexander A. Loboda United States Alexander A. Loboda's profile →
Citations per field
00.5×1.5×
Alexander A. Loboda · 1×
Citations per year

Countries citing papers authored by Muxian Zhang

Since Specialization
Citations

This map shows the geographic impact of Muxian Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muxian Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muxian Zhang more than expected).

Fields of papers citing papers by Muxian Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Muxian Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muxian Zhang. The network helps show where Muxian Zhang may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Muxian Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Muxian Zhang Line = papers co-authored together Muxian Zhang links everyone, so they are left out of the graph.

All Works

6 of 6 papers shown
#Work
1 202121
2 2019145
3
TREM2 Is a Receptor for β-Amyloid that Mediates Microglial Functionbreakdown →
2018519
4 201720
5 201627
6
RAPD analysis on genetic diversity of Pinctada martensii Dunker
20004

About Muxian Zhang

Muxian Zhang is a scholar working on Neurology, Cancer Research and Complementary and alternative medicine, having authored 6 papers that have together received 736 indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (2 papers), Neuroinflammation and Neurodegeneration Mechanisms (2 papers), Genomics and Rare Diseases (1 paper), Ion Transport and Channel Regulation (1 paper), Cancer Genomics and Diagnostics (1 paper), Neurological Disease Mechanisms and Treatments (1 paper), Autophagy in Disease and Therapy (1 paper) and Medicinal Plants and Neuroprotection (1 paper). The work is most often cited by research in Neurology (423 citations), Biological Psychiatry (94 citations) and Physiology (325 citations). Muxian Zhang has collaborated with scholars based in China, United States and Austria. Frequent co-authors include Huaxi Xu, Guojun Bu, Timothy Y. Huang, Yingjun Zhao, Lu-Lin Jiang, Xiaoguang Li, Xilin Wu, Yan Liu, Ningyan Zhang and Juan Piña-Crespo. Their work appears in journals such as Neuron, Molecular Neurobiology and Experimental & Molecular Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026